Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May;33(2):218-29.
doi: 10.1057/jphp.2012.11. Epub 2012 Mar 8.

Roles of pharmacists in expanding access to safe and effective medical abortion in developing countries: a review of the literature

Affiliations
Review

Roles of pharmacists in expanding access to safe and effective medical abortion in developing countries: a review of the literature

Robyn K Sneeringer et al. J Public Health Policy. 2012 May.

Abstract

Unsafe abortion continues to be a major contributor to maternal mortality and morbidity around the world. This article examines the role of pharmacists in expanding women's access to safe medical abortion in Latin America, Africa, and Asia. Available research shows that although pharmacists and pharmacy workers often sell abortion medications to women, accurate information about how to use the medications safely and effectively is rarely offered. No publication covered effective interventions by pharmacists to expand access to medical abortion, but lessons can be learned from successful interventions with other reproductive health services. To better serve women, increasing awareness and improving training for pharmacists and pharmacy workers about unsafe abortion - and medications that can safely induce abortion - are needed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. WHO 2011Unsafe Abortion: Global and Regional Estimates of the Incidence of Unsafe Abortion and Associated Mortality in 20086th edn.Geneva: World Health Organization
    1. WHO 1992The Prevention and Management of Unsafe AbortionReport of a technical working group. Geneva: World Health Organization. Report no. WHO/MSM/92.5.
    1. Tang O.S., Chan C.C., Ng E.H., Lee S.W., Ho P.C. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Human Reproduction. 2003;18 (11:2315–2318. - PubMed
    1. von Hertzen H., et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. British Journal of Obstetrics and Gynecology. 2003;110 (9:808–818. - PubMed
    1. Winikoff B., et al. Two distinct oral routes of misoprostol in mifepristone medical abortion: A randomized controlled trial. Obstetrics and Gynecology. 2008;112 (6:1303–1310. - PubMed

LinkOut - more resources